Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Zhong Ji Longevity Science Group Limited ( (HK:0767) ) has shared an announcement.
Zhong Ji Longevity Science Group Limited announced supplemental information related to its 2024 Annual Report, detailing the use of net proceeds from a subscription. The company fully utilized approximately HK$19.4 million, with 60% allocated to expanding its longevity science and biomedical products trading businesses, and 40% for general working capital. No share options were granted under the 2022 Share Option Scheme during the fiscal year 2024.
The most recent analyst rating on (HK:0767) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Zhong Ji Longevity Science Group Limited stock, see the HK:0767 Stock Forecast page.
More about Zhong Ji Longevity Science Group Limited
Zhong Ji Longevity Science Group Limited operates in the longevity science and biomedical products trading industry. The company focuses on expanding its existing longevity science business and trading new biomedical products.
Average Trading Volume: 910,140
Technical Sentiment Signal: Hold
Current Market Cap: HK$331.1M
Learn more about 0767 stock on TipRanks’ Stock Analysis page.